Bioscience Vaccines, Inc. is an emerging stage, life sciences company with proprietary vaccine development technology. Our technology is based on an abundant, naturally-occurring compound that will make possible great advancements in the fields of prevention and treatment of various disease states. Our product has the potential to be formulated as a companion product with vaccine products already approved and marketed for use by the FDA for the prevention of specific human diseases and by the USDA for the prevention of animal diseases.
An annual market of greater than $2 billion has been estimated with a three-pronged commercialization strategy to ensure success.
The worldwide vaccine market approaches $23.8 billion annually and is growing rapidly. As a companion product formulated with known vaccines, the annual market revenue for Bioscience Vaccines, Inc.’s product is estimated to be in excess of $2 billion. In addition, potential therapeutic uses of our product in emerging markets for the treatment and prevention of cancer could easily double potential annual market revenue. Bioscience Vaccines, Inc. is positioned to be a provider of a key component for both existing and emerging vaccine products for prevention and therapeutic compounds being developed for treatment of disease
Contact us today for more information!
We are currently located at:
1400 Cumberland Avenue
Suite C
West Lafayette, IN 47906-4000
765.464.5890
